MSLN and cancer: For the expression of antigens in tumor tissues, the results indicated that the percentage of FOLR1+MSLN+ cancer cells was significantly decreased in the Tandem-CAR T cell group, while single-target CAR T cells only reduced the corresponding antigen level (p <0.0001, Figure S4).